Company Snapshot Home > Equity > Corporate Information > Company Snapshot
|
|
| Stock Price Details |
|
Chart |
|
|
Last Price (RS)
|
895.20
|
|
Change (%)
|
-1.10 (-0.12%)
|
|
Best Buy (RS)
|
0(x0)
|
|
Best Sell (RS)
|
0(x0)
|
|
Today's Range (RS)
|
851.70
-
909.95
|
|
52-Week Range (RS)
|
300.33
-
999.00
|
|
Beta (1 Year)
|
0.41
|
|
|
|
|
|
| News |
|
Corporate Details |
| Fredun Pharmaceuticals to convene AGM |
| Fredun Pharmaceuticals consolidated net profit rises 79.67% in the March 2026 quarter |
| Board of Fredun Pharmaceuticals approves bonus issue of 2:1 |
| Board of Fredun Pharmaceuticals recommends final dividend |
| Fredun Pharmaceuticals standalone net profit rises 56.58% in the March 2026 quarter |
| Fredun Pharmaceuticals to announce Quarterly Result |
| Fredun Pharmaceuticals sets up its 5th manufacturing unit in Palghar |
| Fredun Pharmaceuticals allots 40,000 equity shares on conversion of warrants |
| Fredun Pharmaceuticals standalone net profit rises 96.62% in the December 2025 quarter |
| Fredun Pharmaceuticals to convene board meeting |
|
|
|
| Incoporation Year : 1987 |
| Chairman : Daulat N Medhora |
| Ownership Group : Indian Private |
| Sector : MAN |
| Industry : Pharmaceuticals - Indian - Formulations |
| Registered Office |
Fredun Pharmaceuticals Ltd
26 Manoj Industrial Premises,
G D Ambedkar Marg Wadala,
Mumbai,
Maharashtra-400031 |
Phone:91-22-40318111
Fax: |
| E-Mail : business@fredungroup.com |
| URL : http://www.fredungroup.com |
|
| Investor Returns |
|
| |
Date |
Price |
Returns (%) |
| 1Week |
17-Jul-2026 |
955.20 |
-6.28 |
| 1Month |
24-Jun-2026 |
860.62 |
4.02 |
| 3Month |
24-Apr-2026 |
704.29 |
27.11 |
| 6Month |
27-Jan-2026 |
495.96 |
80.50 |
| 1Year |
24-Jul-2025 |
305.48 |
193.05 |
|
|
|
|
| Mutual Funds Holding |
|
| No Data Found |
|
|
|
| Groups : Pharmaceuticals - Indian - Formulations |
|
| Company |
Last Price |
Change (%) |
52Week High |
52Week Low |
Market Cap (Rs Cr.) |
| Torrent Pharmaceuticals Ltd |
4,959.80 |
-2.09 |
5,084.85 |
3,480.00 |
188,654.85 |
| Ajanta Pharma Ltd |
3,366.45 |
-2.16 |
3,598.40 |
2,335.00 |
42,058.95 |
| Gland Pharma Ltd |
2,378.35 |
0.03 |
2,574.00 |
1,575.00 |
39,233.19 |
| Rubicon Research Ltd |
1,519.10 |
-0.78 |
1,545.60 |
571.00 |
25,123.29 |
| ERIS Lifesciences Ltd |
1,398.90 |
0.27 |
1,887.65 |
1,237.90 |
19,385.75 |
|
|
|
|